Jeong-Eun Lee

发表

First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea

Y. Chang, Shin‐Yup Lee, Chang-Min Choi, 2022, AntiCancer Research.

Progression-Free Survival: An Important Prognostic Marker for Long-Term Survival of Small Cell Lung Cancer

Yeon-Hee Park, D. Park, S. Jung, 2014, Tuberculosis and respiratory diseases.

Characteristics and clinical outcomes of patients with nonsmoking small cell lung cancer in Korea

J. Ahn, Youngchul Kim, S. H. Lee, 2021, BMC Pulmonary Medicine.

Sequential Treatment of Afatinib and Osimertinib in Patients with Advanced Non-small Cell Lung Cancer Harboring EGFR Mutations: Results from a Real-world Study in South Korea

Mi Hyun Kim, Y. Chang, Shin‐Yup Lee, 2021 .

Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy

Yeon-Hee Park, D. Park, S. Jung, 2015, Tuberculosis and respiratory diseases.

Comparative outcomes of lopinavir/ritonavir and hydroxychloroquine for the treatment of coronavirus disease 2019 with mild to moderate severity.

Dong-Wan Kim, S. H. Lee, Shinwon Lee, 2020 .

The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer

C. Chung, Jeong-Eun Lee, D. Kang, 2022, Thoracic cancer.

Nationwide population-based incidence of cancer among patients with HIV/AIDS in South Korea

S. H. Lee, Shinwon Lee, Hyunjin Son, 2022, Scientific Reports.

Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea

Y. Chang, Shin‐Yup Lee, I. Oh, 2021, Translational lung cancer research.

Real-world Outcomes of First-line Afatinib in Patients with Non-small Cell Lung Cancer and Uncommon EGFR Mutations in South Korea

Mi Hyun Kim, Y. Chang, Shin‐Yup Lee, 2021 .

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer

Jae Cheol Lee, Shin‐Yup Lee, S. Jang, 2022, Cancer research and treatment.

Changing trends in the incidence and spectrum of cancers between 1990 and 2021 among HIV-infected patients in Busan, Korea.

Shinwon Lee, S. Lee, J. Kang, 2023, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Abstract 75: Patient-specific genomic profiling for advanced cancers in young adults

Jong-Yeon Shin, Se-Hoon Lee, Jong-Il Kim, 2015 .

A Prospective Observational Study Evaluating the Correlation of c-MET Expression and EGFR Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung Cancer

Shin‐Yup Lee, I. Oh, J. Ryu, 2018, Oncology.

Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.

Gwan Ho Lee, Kyu-Sik Kim, K. Shin, 2012, Lung cancer.

Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015

J. Ahn, K. S. Beck, K. Jung, 2022, Cancer research and treatment.

Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer

Su Yeon Lee, Shin‐Yup Lee, Chang-Min Choi, 2021, Thoracic cancer.

An explorative study using next generation sequencing of papillary renal cell carcinoma, type 2

J. Y. Kim, Se-Hoon Lee, Soojin Cha, 2015 .

Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial

I. Oh, Kyu-Sik Kim, K. Shin, 2016, BMC Cancer.

Clinical characteristics of non-small cell lung cancer patients who experienced acquired resistance during gefitinib treatment.

Gwan Ho Lee, J. Son, I. Oh, 2014, Lung cancer.

Characteristics of female lung cancer in Korea: analysis of Korean National Lung Cancer Registry

J. Ahn, C. Choi, Y. Won, 2020, Journal of thoracic disease.

Seroprevalence of Helicobacter pylori in human immunodeficiency virus-infected patients in a tertiary care hospital in Busan, South Korea.

Shinwon Lee, S. Lee, J. Kang, 2022, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Regdanvimab in patients with mild-to-moderate SARS-CoV-2 infection: A propensity score–matched retrospective cohort study

Shinwon Lee, K. Kwon, Hyun-Ha Chang, 2022, International Immunopharmacology.

Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer

C. Chung, Y. Kang, Jeong-Eun Lee, 2022, Journal of Cancer Research and Clinical Oncology.

Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial

I. Oh, Kyu-Sik Kim, K. Shin, 2016, BMC Cancer.

The Tri-iodothyronine (T3) Level Is a Prognostic Factor for Patients With Advanced NSCLC: Receiving Immune Checkpoint Inhibitors and Is Associated With Liver Metastasis

C. Chung, Jeong-Eun Lee, D. Kang, 2022, Clinical Medicine Insights. Oncology.

The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in Korea.

Shin‐Yup Lee, Y. Noguchi, S. Jang, 2015, Lung cancer.

Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial

Jae Cheol Lee, Shin‐Yup Lee, I. Oh, 2023, Cells.

A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung cancer (stage III) who have not progressed following definitive, platinum‐based, chemoradiation therapy (PLATINUM trial)

I. Oh, Chang-Min Choi, Juwhan Choi, 2022, Thoracic cancer.

Stevens–Johnson Syndrome and Hypothermia Associated with Anti-tuberculosis Medication in a Patient with Heart Failure

D. Park, S. Jung, H. Park, 2015, Chinese medical journal.

Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non–Small Cell Lung Cancer: Updated Analysis of the RESET Study

Y. Chang, Shin‐Yup Lee, S. Jang, 2023, Cancer research and treatment.

Severe mediastinitis and pericarditis after endobronchial ultrasound-guided transbronchial needle aspiration: A case report

Jeong-Eun Lee, D. Kang, Song-I Lee, 2021, World Journal of Clinical Cases.

The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in Korea.

Shin‐Yup Lee, Y. Noguchi, S. Jang, 2015, Lung Cancer.

Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer

Chang-Min Choi, J. Lim, Sung-Yong Lee, 2024, Cancers.

Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors

Mi Hyun Kim, Y. Chang, Shin‐Yup Lee, 2023, Translational lung cancer research.

Real‐world evidence of brigatinib as second‐line treatment after crizotinib for ALK+ non‐small cell lung cancer using South Korean claims data (K‐AREAL)

Jeong-Eun Lee, Jin Hyun Nam, Sun Hong Kwon, 2024, Cancer medicine.